Market loves Cardinal Health’s Kinray acquisition
Investors showed their approval of Cardinal Health Inc.'s (NYSE:CAH) $1.3 billion acquisition of drug distributor Kinray Inc., bidding up Cardinal's shares to their largest daily gain in a year and a half on Thursday.